In a unanimous decision, the nation’s highest court has made a clear delineation as to who bears the burden of proof in ERISA litigation — and it’s not likely to slow the current pace.

The diagnostic vials market share analysis is anticipated to expand at a consistent compound annual growth rate (CAGR) from 2025 to 2035. Demand is primarily driven by the growing prevalence of ...